Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Zhongzhikanggu Biotechnology is a specialized health technology company focused on the research, cultivation, and processing of medicinal mushrooms. The company primarily utilizes biotechnology to develop high-potency extracts from fungi such as Ganoderma lucidum (Lingzhi) and Cordyceps. Their core product offerings include cell-wall broken spore powders and concentrated polysaccharide extracts designed for immune system modulation and general health maintenance. Based in Hangzhou, China, the firm integrates traditional mycological knowledge with modern extraction techniques to serve the domestic and international nutraceutical markets. The company operates as a private entity, focusing on the commercialization of functional food and health supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 杭州众芝康菇生物技术.